Lu Zhang

Dr. Lu Zhang

Zhejiang Cancer Hospital
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2020 in Nature Nanotechnology
Verified
Journal Article
Closed access
PDF file
LZLu Zhang
Lu Zhang
DJDi Jing
Di Jing
NJNian Jiang
Nian Jiang
TRTatu Rojalin
Tatu Rojalin
CBChristopher M. Baehr
Christopher M. Baehr
KLKit S. Lam
Kit S. Lam

5 February 2020 in ACS Nano
Verified
Journal Article
Closed access
Zhaoqing CongZhaoqing Cong
Zhaoqing Cong
LZLu Zhang
Lu Zhang
SMSi-Qi Ma
Si-Qi Ma
KLKit S. Lam
Kit S. Lam
FYFei-Fei Yang
Fei-Fei Yang
YLYonghong Liao
Yonghong Liao

7 October 2020 in RSC Advances
Verified
Journal Article
Open access
PDF file
MCMengru Cai
Mengru Cai
LQLiuying Qin
Liuying Qin
LYLongtai You
Longtai You
YYYu Yao
Yu Yao
HWHuimin Wu
Huimin Wu
JNJian Ni
Jian Ni
Metal organic frameworks (MOFs) are widely used in drug carrier research due to their tunability. The properties of MOFs can be adjusted through incorporation of mono-substituents to obtain pharmaceutical carriers with excellent properties. In this study, different functional groups of –NH2, –CH3, –Br, –OH and –CH2 CH are connected to MOF-5 to analyse the effect of mono-substituent incorporation on drug delivery properties. The resulting MOFs have similar structures, except for Br–MOF. The pore size of this series of MOFs ranges from 1.04 nm to 1.10 nm. Using oridonin (ORI) as a model drug, introduction of the functional groups appears to have a significant effect on the drug delivery performance of the MOFs. The IRMOFs can be ranked according to drug-loading capacity: MOF-5 > HO–MOF-5 > H3C–MOF-5 = Br–MOF-5 > H2N–MOF-5 > CH2 CH–MOF-5. The ORI release from ORI @IRMOFs is explored at two different pH values: 7.4 and 5.5, and the ORI@IRMOFs are ranked according to the cumulative release percentage of ORI: ORI@MOF-5 > ORI@Br–MOF-5 > ORI@H3C–MOF-5 > ORI@H2N–MOF-5 > CH2 CH–MOF-5 > ORI@ HO–MOF-5. In particular, the release behaviour of ORI@MOFs is described through a new model. The different drug delivery performance of MOFs may be due to the complex interactions between MOFs and ORI. In addition, the introduction of single substituents does not change the biocompatibility of MOFs. MTT in vitro experiments prove that this series of MOFs has low cytotoxicity. This study shows that the incorporation of single substituents can effectively adjust the drug delivery behaviour of MOFs, which is conducive to realization of personalized drug delivery modes. The introduction of active groups can also facilitate post-synthesis modification to achieve coupling of targeting groups. MOFs incorporated with single substituents perform favorably in terms of use as biomedical drug delivery alternative carriers in effective drug payload and flexible drug release.

1 November 2013 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
LQLi-Yan Qiu
Li-Yan Qiu
LYLu Yan
Lu Yan
LZLu Zhang
Lu Zhang
YJYang-Min Jin
Yang-Min Jin
QZQing-He Zhao
Qing-He Zhao

23 July 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
PYPei-Pei Yang
Pei-Pei Yang
YLYi-Jing Li
Yi-Jing Li
YCYan Cao
Yan Cao
LZLu Zhang
Lu Zhang
JWJia-Qi Wang
Jia-Qi Wang
KLKit S. Lam
Kit S. Lam
Self-assembling peptides have shown tremendous potential in the fields of material sciences, nanoscience, and medicine. Because of the vast combinatorial space of even short peptides, identification of self-assembling sequences remains a challenge. Herein, we develop an experimental method to rapidly screen a huge array of peptide sequences for self-assembling property, using the one-bead one-compound (OBOC) combinatorial library method. In this approach, peptides on beads are N-terminally capped with nitro-1,2,3-benzoxadiazole, a hydrophobicity-sensitive fluorescence molecule. Beads displaying self-assembling peptides would fluoresce under aqueous environment. Using this approach, we identify eight pentapeptides, all of which are able to self-assemble into nanoparticles or nanofibers. Some of them are able to interact with and are taken up efficiently by HeLa cells. Intracellular distribution varied among these non-toxic peptidic nanoparticles. This simple screening strategy has enabled rapid identification of self-assembling peptides suitable for the development of nanostructures for various biomedical and material applications.

19 October 2018 in Nano Letters
Verified
Journal Article
Closed access
LZLu Zhang
Lu Zhang
DJDi Jing
Di Jing
LWLei Wang
Lei Wang
YSYuan Sun
Yuan Sun
JLJian Jian Li
Jian Jian Li
KLKit S. Lam
Kit S. Lam